The present data clearly demonstrate that lactobacilli can modulate the cytokine induction profiles in hPBMC of allergic subjects in vitro. This modulation was most obvious in an increase in innate cytokine induction and a decreased synthesis of the Th2 cytokine IL-13 observed for all tested strains. Based on the present study, strains B1836, B2261,
the mixture of B2261 and B633, and B633 alone could be chosen as most promising probiotic strains because of their stronger inhibition potential of IL-13 induction and higher induction of IFN-γ and IL-12 compared with the other tested strains. Furthermore, the analysis presented here provides a suitable model to compare candidate probiotic strains www.selleckchem.com/products/gsk2126458.html find more for their
immunomodulating properties in vitro in a Th2-skewed population and can even be used outside the pollen season, which makes this methodology a useful screening model. We thank Sovianne ter Borg for technical assistance, ZGV (Gelderse Valley Hospital; Ede, the Netherlands) for providing patient-related data, Dr H. Verhoef and J. Veenemans for their expert statistical advice and Dr H. Yssel is kindly thanked for supplying the Yssel supplement. “
“Chronic inflammatory T-cell-mediated diseases such as inflammatory bowel disease (IBD) are often treated with immunosuppressants including corticosteroids. In addition to the intended T-cell suppression, these farmacons give rise to many side effects. Recently, immunosuppressive phospholipids have been proposed as less-toxic alternatives. We aimed to investigate the immunoregulatory capacities of the naturally occurring phospholipid phosphatidylinositol (PI). Systemic PI treatment dramatically reduced disease severity and intestinal inflammation in murine 2,4,6-trinitrobenzene sulfonic acid (TNBS) colitis. Moreover, PI Loperamide treatment inhibited the inflammatory T-cell response in these mice, as
T cells derived from colon-draining LN of PI-treated mice secreted less IL-17 and IFN-γ upon polyclonal restimulation when compared to those of saline-treated mice. Further characterization of the suppressive capacity of PI revealed that the phospholipid suppressed Th cell differentiation in vitro irrespective of their cytokine profile by inhibiting proliferation and IL-2 release. In particular, PI diminished IL-2 mRNA expression and inhibited ERK1-, ERK-2-, p38- and JNK-phosphorylation. Crucially, PI did not ablate Treg differentiation or the antigen-presenting capacity of DCs in vitro. These data validate PI as a pluripotent inhibitor that can be applied mucosally as well as systemically. Its compelling functions render PI a promising novel physiological immune suppressant.